Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits

Author： Chouinard Sylvie   Stip Emmanuel   Poulin Julie   Melun Jean-Pierre   Godbout Roger   Guillem François   Cohen Henri  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.3, 2007-03, pp. : 575-583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease

By  

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 30, Iss. 9, 2015-09 ,pp. : 965-975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Specificity of Cognitive Deficits in Bipolar Disorder versus Schizophrenia

By  

Psychotherapy and Psychosomatics, Vol. 75, Iss. 2, 2006-03 ,pp. : 72-84

Karger

Access to resources Recommend Favorite

Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan

By Hanif W.  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 807-811

Informa Healthcare

Access to resources Recommend Favorite

Long‐term treatment with empagliflozin as add‐on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 665-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension

By  

Respiration, Vol. 94, Iss. 3, 2017-08 ,pp. : 263-271

Karger

Access to resources Recommend Favorite